Akero Therapeutics, Inc.·4

Jun 27, 5:58 PM ET

Judy Chou 4

4 · Akero Therapeutics, Inc. · Filed Jun 27, 2023

Insider Transaction Report

Form 4
Period: 2023-06-23
Judy Chou
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-06-23+15,00015,000 total
    Exercise: $50.83Exp: 2033-06-22Common Stock (15,000 underlying)
Footnotes (1)
  • [F1]This option shall vest in full upon the earlier of (i) June 23, 2024 or (ii) the date of the next annual meeting, all vesting shall cease if the director resigns from the Board or otherwise ceases to service as a director.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4